BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15475343)

  • 1. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells.
    Chu JJ; Ng ML
    J Biol Chem; 2004 Dec; 279(52):54533-41. PubMed ID: 15475343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.
    Chu JJH; Rajamanonmani R; Li J; Bhuvanakantham R; Lescar J; Ng ML
    J Gen Virol; 2005 Feb; 86(Pt 2):405-412. PubMed ID: 15659760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of Kaposi's sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptor.
    Garrigues HJ; Rubinchikova YE; Dipersio CM; Rose TM
    J Virol; 2008 Feb; 82(3):1570-80. PubMed ID: 18045938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrins modulate the infection efficiency of West Nile virus into cells.
    Schmidt K; Keller M; Bader BL; Korytář T; Finke S; Ziegler U; Groschup MH
    J Gen Virol; 2013 Aug; 94(Pt 8):1723-1733. PubMed ID: 23658209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT5: a Target of Antagonism by Neurotropic Flaviviruses.
    Zimmerman MG; Bowen JR; McDonald CE; Young E; Baric RS; Pulendran B; Suthar MS
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Molecular Determinant of West Nile Virus Secretion and Morphology as a Target for Viral Attenuation.
    Basset J; Burlaud-Gaillard J; Feher M; Roingeard P; Rey FA; Pardigon N
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of plasma membrane-associated proteins from Aedes albopictus mosquito (C6/36) cells that mediate West Nile virus binding and infection.
    Chu JJ; Leong PW; Ng ML
    Virology; 2005 Sep; 339(2):249-60. PubMed ID: 15992848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo activity of AS101 against West Nile virus (WNV).
    Indenbaum V; Bin H; Makarovsky D; Weil M; Shulman LM; Albeck M; Sredni B; Mendelson E
    Virus Res; 2012 Jun; 166(1-2):68-76. PubMed ID: 22445690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin.
    Medigeshi GR; Hirsch AJ; Streblow DN; Nikolich-Zugich J; Nelson JA
    J Virol; 2008 Jun; 82(11):5212-9. PubMed ID: 18385233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells.
    Hershkovitz O; Rosental B; Rosenberg LA; Navarro-Sanchez ME; Jivov S; Zilka A; Gershoni-Yahalom O; Brient-Litzler E; Bedouelle H; Ho JW; Campbell KS; Rager-Zisman B; Despres P; Porgador A
    J Immunol; 2009 Aug; 183(4):2610-21. PubMed ID: 19635919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication-Defective West Nile Virus with NS1 Deletion as a New Vaccine Platform for Flavivirus.
    Li N; Zhang YN; Deng CL; Shi PY; Yuan ZM; Zhang B
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrin.
    Lee JW; Chu JJ; Ng ML
    J Biol Chem; 2006 Jan; 281(3):1352-60. PubMed ID: 16275649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the endocytic pathway mediating the infectious entry of mosquito-borne flavivirus West Nile into Aedes albopictus mosquito (C6/36) cells.
    Chu JJ; Leong PW; Ng ML
    Virology; 2006 Jun; 349(2):463-75. PubMed ID: 16490225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection.
    Pierson TC; Sánchez MD; Puffer BA; Ahmed AA; Geiss BJ; Valentine LE; Altamura LA; Diamond MS; Doms RW
    Virology; 2006 Mar; 346(1):53-65. PubMed ID: 16325883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.
    Goo L; Debbink K; Kose N; Sapparapu G; Doyle MP; Wessel AW; Richner JM; Burgomaster KE; Larman BC; Dowd KA; Diamond MS; Crowe JE; Pierson TC
    Nat Microbiol; 2019 Jan; 4(1):71-77. PubMed ID: 30455471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
    Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
    J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the role of integrin subunits alpha 2 and beta 3 in rotavirus cell entry by RNA silencing.
    Isa P; Sánchez-Alemán MA; López S; Arias CF
    Virus Res; 2009 Nov; 145(2):251-9. PubMed ID: 19635510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus.
    Li SH; Li XF; Zhao H; Jiang T; Deng YQ; Yu XD; Zhu QY; Qin ED; Qin CF
    Immunol Lett; 2011 Aug; 138(2):156-60. PubMed ID: 21515306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusion of West Nile virus superinfection through RNA replication.
    Zou G; Zhang B; Lim PY; Yuan Z; Bernard KA; Shi PY
    J Virol; 2009 Nov; 83(22):11765-76. PubMed ID: 19726510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells.
    Silva MC; Guerrero-Plata A; Gilfoy FD; Garofalo RP; Mason PW
    J Virol; 2007 Dec; 81(24):13640-8. PubMed ID: 17913823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.